Eric Goemaere
Overview
Explore the profile of Eric Goemaere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
2225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tekpa G, Inikoutiyo J, Yonli C, Noguera C, Lujwiro P, Gigout L, et al.
J Int AIDS Soc
. 2024 Dec;
27(12):e26387.
PMID: 39639546
Introduction: The retention in care of patients undergoing antiretroviral therapy (ART) is a cornerstone for preventing AIDS-associated morbidity and mortality, as well as further transmission of HIV. Adherence to ART...
2.
Conan N, Paye C, Ortuno R, Chijuwa A, Chiwandira B, Goemaere E, et al.
PLoS One
. 2024 Feb;
19(2):e0299866.
PMID: 38412175
[This corrects the article DOI: 10.1371/journal.pone.0248410.].
3.
Keene C, Cassidy T, Zhao Y, Griesel R, Jackson A, Sayed K, et al.
J Acquir Immune Defic Syndr
. 2023 Jan;
92(5):422-429.
PMID: 36706364
Background: Recycling tenofovir and lamivudine/emtricitabine with dolutegravir (TLD) after failure of non-nucleoside transcriptase inhibitor first-line antiretroviral therapy is more tolerable and scalable than dolutegravir plus optimized nucleoside reverse transcriptase inhibitors....
4.
Zhao Y, Keene C, Griesel R, Sayed K, Gcwabe Z, Jackson A, et al.
Wellcome Open Res
. 2022 Aug;
6:33.
PMID: 36017341
Dolutegravir has superior efficacy and tolerability than lopinavir-ritonavir in second-line antiretroviral therapy after failure of a first-line non-nucleoside reverse transcriptase inhibitors-based regimen, when dolutegravir is accompanied by at least one...
5.
Keene C, Griesel R, Zhao Y, Gcwabe Z, Sayed K, Hill A, et al.
AIDS
. 2021 May;
35(9):1423-1432.
PMID: 33973876
Objective: Recycling tenofovir and lamivudine/emtricitabine (XTC) with dolutegravir would provide a more tolerable, affordable, and scalable second-line regimen than dolutegravir with an optimized nucleoside reverse transcriptase inhibitor (NRTI) backbone. We...
6.
Conan N, Paye C, Ortuno R, Chijuwa A, Chiwandira B, Goemaere E, et al.
PLoS One
. 2021 Apr;
16(4):e0248410.
PMID: 33886575
Introduction: The Malawi Ministry of Health (MoH) has been in collaboration with Médecins sans Frontières (MSF) to increase access to quality HIV care through decentralization of antiretroviral therapy (ART) diagnosis...
7.
Osler M, Cornell M, Ford N, Hilderbrand K, Goemaere E, Boulle A
J Int AIDS Soc
. 2020 Jun;
23 Suppl 2:e25530.
PMID: 32589367
Introduction: Few studies have systematically described population-level differences comparing men and women across the continuum of routine HIV care. This study quantifies differentials in HIV care, treatment and mortality outcomes...
8.
Ford N, Goemaere E, Hildebrand K, Perez-Casas C
Clin Infect Dis
. 2020 May;
71(9):2500-2501.
PMID: 32369101
No abstract available.
9.
Chihana M, Huerga H, Van Cutsem G, Ellman T, Goemaere E, Wanjala S, et al.
Glob Health Action
. 2019 Nov;
12(1):1679472.
PMID: 31679482
: Despite substantial progress in antiretroviral therapy (ART) scale up, some people living with HIV (PLHIV) continue to present with advanced HIV disease, contributing to ongoing HIV-related morbidity and mortality.:...
10.
Venables E, Casteels I, Sumbi E, Goemaere E
PLoS One
. 2019 Feb;
14(2):e0211619.
PMID: 30759138
Introduction: HIV prevalence in the Democratic Republic of Congo (DRC) is estimated to be 1.2%, and access to HIV testing and treatment remains low across the country. Despite advances in...